Skip to content

Revoke Mylan’s Corporate Charter

September 5, 2016

Something needs to be done to stop the price gouging by the pharmaceutical industry. Perhaps this would be a good place to start.
– RJC

Mike the Mad Biologist

By now, you’ve probably heard about Mylan Laboratories’ massive price hikes in the EpiPen, which is used to treat life-threatening allergic reactions. You might have even heard how the EpiPen technology is entirely the result of federally funded research. Perhaps you even read about the possible (who are we kidding, probable) anti-trust violations that Mylan has committed. But this is simply par for the course (boldface mine):

EpiPen price hikes may be causing outrage, but those pale in comparison to the huge increases that Mylan Laboratories took on dozens of other medicines earlier this year.

For instance, the company raised the price of ursodiol, a generic medicine used to treat gallstones, by 542 percent. There was also a 400 percent boost in the price for dicyclomine, which combats irritable bowel syndrome, and a 312 percent increase for metoclopramide, a generic drug that treats gastroesophageal reflux disease.

Those eye-popping…

View original post 352 more words

Advertisements

From → Uncategorized

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: